Abstract
Background As an increasing number of patients exhibit concomitant cardiac and pulmonary disease, limitations of standard diagnostic criteria are more frequently encountered. Here, we apply noninvasive 129Xenon MR imaging and spectroscopy to identify patterns of regional gas transfer impairment and hemodynamics that are uniquely associated with chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), left heart failure (LHF), and pulmonary arterial hypertension (PAH).
Methods Healthy volunteers (n=23) and patients with COPD (n=8), IPF (n=12), LHF (n=6), and PAH (n=10) underwent 129Xe gas transfer imaging and dynamic spectroscopy. For each patient, 3D maps were generated to depict ventilation, barrier uptake (129Xe dissolved in interstitial tissue), and red blood cell (RBC) transfer (129Xe dissolved in RBCs). Dynamic 129Xe spectroscopy was used to quantify cardiogenic oscillations in the RBC signal amplitude and frequency shift.
Results Compared to healthy volunteers, all patient groups exhibited decreased ventilation and RBC transfer (p≤0.01, p≤0.01). Patients with COPD demonstrated more ventilation and barrier defects compared to all other groups (p≤0.02, p≤0.02). In contrast, IPF patients demonstrated elevated barrier uptake compared to all other groups (p≤0.007) and increased RBC amplitude and shift oscillations compared to healthy volunteers (p=0.007, p≤0.01). Patients with COPD and PAH both exhibited decreased RBC amplitude oscillations (p=0.02, p=0.005) compared to healthy volunteers. LHF was distinguishable from PAH by enhanced RBC amplitude oscillations (p=0.01).
Conclusion COPD, IPF, LHF, and PAH each exhibit unique 129Xe MR imaging and dynamic spectroscopy signatures. These metrics may help with diagnostic challenges in cardiopulmonary disease and increase understanding of regional lung function and hemodynamics at the alveolar-capillary level.
Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Wang reports In addition, Dr. Wang has a patent Provisional patent licensed.
Conflict of interest: Dr. Bier reports grants from National Institutes of Health, during the conduct of the study; In addition, Dr. Bier has a patent Provisional patent licensed.
Conflict of interest: Dr. Swaminathan has nothing to disclose.
Conflict of interest: Dr. Parikh has nothing to disclose.
Conflict of interest: Dr. Nouls has nothing to disclose.
Conflict of interest: Dr. He has nothing to disclose.
Conflict of interest: Dr. Mammarappallil has nothing to disclose.
Conflict of interest: Dr. Luo has nothing to disclose.
Conflict of interest: Dr. Driehuys reports grants from National Institutes of Health, during the conduct of the study; personal fees and other from Polarean Imaging, outside the submitted work; In addition, Dr. Driehuys has a patent Provisional patent licensed.
Conflict of interest: Dr. Rajagopal reports grants from National Institutes of Health, during the conduct of the study; In addition, Dr. Rajagopal has a patent “Dynamic 129Xe Gas Exchange Spectroscopy” pending.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received April 29, 2019.
- Accepted September 12, 2019.
- Copyright ©ERS 2019